Clairity Breast is the first FDA-authorized AI platform that predicts a woman’s five-year future risk of developing breast cancer, using only her existing screening mammogram.
“For more than 60 years, mammograms have saved lives by detecting early-stage cancers. Now, advancements in AI and computer vision can uncover hidden clues in the mammograms – invisible to the human eye – to help predict future risk. By delivering validated, equitable risk assessments, we can help expand access to life-saving early detection and prevention for women everywhere.”
Dr. Connie Lehman
During the broadcast, Dr. Connie Lehman shared a five-year breast cancer risk estimate for NBC anchor Savannah Sellers, generated from her mammogram images by the CLAIRITY BREAST AI platform.
Clairity, Inc., a company pioneering AI-powered risk prediction in human health, today announced that Founder Dr. Connie Lehman has been named to the Forbes “50 Over 50: Innovation” list.
Clairity Inc., a leader in AI-based breast cancer risk prediction, today announced that five scientific presentations featuring its FDA-authorized image-only AI model will be presented at the Radiological Society of North America (RSNA) 2025 Annual Meeting, taking place November 30 to December 4 in Chicago.
Clairity is launching soon at health systems across the USA. Sign up to be notified when it’s available at a health system near you.
